市場調査レポート - 86309

世界の動物医療用製品(動物用医薬品、ワクチン、OTC薬、能力向上薬)

World Veterinary Health Products (Animal Pharmaceuticals, Vaccines, OTC and Performance Enhancers)

発行 Kalorama Information
出版日 ページ情報 英文 160 pages
電子版即納可
価格
こちらの商品の販売は終了いたしました。
世界の動物医療用製品(動物用医薬品、ワクチン、OTC薬、能力向上薬) World Veterinary Health Products (Animal Pharmaceuticals, Vaccines, OTC and Performance Enhancers)
出版日: 2009年05月01日 ページ情報: 英文 160 pages

当商品の販売は、2014年06月20日を持ちまして終了しました。

概要

当報告書では、動物用医薬品、OTC薬、能力向上薬、動物用ワクチンの各セグメントに関する機会と参入企業および新規参入企業の概要とともに、2014年までの市場予測、米国、欧州などの地域別収益などを織り交ぜ、概略下記の内容でお届けいたします。

第1章 動物用医薬品市場:戦略的見通し

  • 回復市場
  • 疫学
  • 動物用医薬品業界構造
  • 市場
  • 市場セグメント
  • 顧客セグメント
  • 市場規模と成長
  • 地域別動向
  • 競合
  • 買収および合併
  • 研究開発
  • 将来の業界拡大動向

第2章 動物医薬品市場

  • 背景
  • 市場規模と成長
  • 市場セグメント
  • 競合
  • 主な市場動向

第3章 動物用ワクチン市場

  • 背景
  • 動物の病気とワクチン接種
  • ワクチンの利点
  • 病気のコスト
  • ワクチンの開発
  • ワクチン接種ガイドライン
  • 市場規模と成長
  • 地域別動向
  • 競合シェア
  • ワクチン開発のハードル
  • 規制の側面
  • ワクチンの整合指針に関する国際協力
  • 動物用ワクチンのライセンシング手順
  • 将来動向

第4章 動物能力向上薬市場

  • 背景
  • 飼料添加物
  • 市場規模と成長
  • 市場セグメント
  • 地域別動向
  • 競合
  • インプラントと注射
  • 規制の枠組み
  • 安全性の問題

第5章 動物用OTC薬市場

  • 背景
  • ペット数動向
  • 市場規模と成長
  • 市場セグメント
  • 市場促進因子
  • 製品ライフサイクルマネジメント
  • 規制の問題

第6章 企業プロファイル

図表

目次

Abstract

The multi-billion veterinary health products market, though smaller in opportunity as compared with the human health sector, offers significant return on investment, primarily driven by lower risk and faster product development cycles. The veterinary health products market has remained resilient over the economic downturns of the past 2 decades.

This report, World Veterinary Health Products, takes a look at veterinary health products for both companion (pet) animals, and production animals (livestock and poultry) and the opportunity for existing players and new entrants in three segments:

  • Pharmaceuticals (including Parasiticides, Anti-infectives, NSAIDS, Cardiovasculars, Hormones, CNS, Others)
  • Veterinary (Pet) OTC Products (Parasiticides, NSAIDS, Vitamins, GI Disorders, Cold and Cough, Others)
  • Performance Enhancers
  • Veterinary Vaccines

For each segment, the report includes pet and production animal demographic information, market forecasts to 2014, major products in the industry, trends affecting business planning, and competitive activity. Revenues are provided for U.S., Europe and Rest of World. This report profiles the following key companies in this industry: This report profiles the following key companies in this industry:

  • Alpharma Animal Health
  • Adisseo France S.A.S.
  • BASF International
  • Bayer Healthcare
  • Boehringer Ingelheim GmbH
  • DSM Nutritional Products, Inc.
  • Elanco Animal Health
  • Fort Dodge Animal Health
  • Heska Corporation
  • Intervet Schering Plough Animal Health
  • Merial Animal Health Ltd.
  • Novartis Animal Health Inc.
  • Virbac SA
  • Pfizer Animal Health
  • This report was constructed with secondary research into annual reports, government health data, trade and medical journals, supplemented with phone and email interviews with executives and experts in the industry. Interviews were used to test assumptions and fix forecasts in the report.

Table of Contents

CHAPTER ONE: VETERINARY HEALTH PRODUCTS MARKET- STRATEGIC PERSPECTIVES

  • 1.1. A Resilient Market, Even in Downturns
  • 1.2. Epidemiology
    • Livestock
    • Pets
  • 1.3. Veterinary Health Products Industry Structure
    • 1.3.1. Key Factors Affecting the Industry
      • a) Threat of Generics
      • b) Lack of innovation
      • c) Expectations
      • d) High dependence on the product
  • 1.4. Market
  • 1.5. Market Segments
    • 1.5.1 Companion Animal Products (CAP
      • Pet Insurance Market
      • Factors affecting the growth of Pet Insurance
    • 1.5.2. Food Animal Products (FAP)
      • a) Leading Growth Drivers
  • 1.6. Customer Segments
    • a) Veterinary Hospitals
    • b) Farms
    • c) Pet Owners
  • 1.7. Market Size and Growth
  • 1.8. Market Segments
    • 1.8.1. Veterinary Pharmaceuticals Market
    • 1.8.2. Veterinary Vaccines Market
    • 1.8.3. Veterinary Performance Enhancers Market
  • 1.9. Geography
  • 1.10. Species
  • 1.11. Competition
  • 1.12. Mergers and Acquisitions
  • 1.13. Research and Development
    • a) Leading R&D trends in the Animal Health Industry
  • 1.14. Future Industry trends for Growth
    • a) Shift from product to market focus
    • b) Enhanced focus on R&D
    • c) Consolidation and Globalization

CHAPTER TWO: VETERINARY PHARMACEUTICAL PRODUCTS MARKET

  • 2.1. Background
    • a) Preventative medicines
    • b) Therapeutic Medicines
    • c) Others
  • 2.2. Market Size and Growth
  • 2.3. Market Segments
    • 2.3.1. Veterinary Anti-Infective Market
    • 2.3.2. Veterinary Anti-inflammatory Products Market
    • 2.3.3. Veterinary Cardiovascular Products Market
    • 2.3.4. Veterinary Parasiticidal Products Market
    • 2.3.5. Veterinary CNS disorders Products Market
    • 2.3.6. Veterinary Hormonal Products Market
  • 2.4. Competition
  • 2.5. Leading Market Trends
    • a) Generics threat
    • b) New technologies and innovations
    • c) New geographical market growth

CHAPTER THREE: VETERINARY VACCINES MARKET

  • 3.1. Background
  • 3.2. Veterinary Diseases & Vaccination
    • 3.2.1. Vaccine Types
      • a) Live vaccines
      • b) Dead vaccines
    • 3.2.2. Livestock Vaccination
      • a) Cattle Vaccines
      • b) Sheep Vaccines
      • c) Goat Vaccines
      • d) Pig Vaccines
      • e) Swine Vaccines
    • 3.2.3. Pet vaccines
      • a) Background
      • b) Current guidelines
    • 3.2.4. Poultry vaccines
  • 3.3. Vaccination Advantages
    • a) Cost containment
    • b) Reduction in antibiotic use
    • c) Improvement in human health
    • d) Impact on the industry
    • e) Good Health, consistent throughput
  • 3.4. Disease costs
  • 3.5. Vaccine development
    • a) Development Process
    • b) Equipment
  • 3.6. Vaccination Guidelines
  • 3.7. Market Size and Growth
  • 3.8. Geographical split
  • 3.9. Competitive Share
    • a) Demand Drivers: Positive Factors
    • b) Demand: Negative Factors
    • 3.10. Hurdles in Vaccine Development
    • a) Biological and technical obstacles
    • b) Economic obstacles
    • c) Target complexity and diversity
  • 3.11. Regulatory Aspects
  • 3.12. International Cooperation on Harmonization Guidelines for Vaccines
  • 3.13. Procedures for licensing veterinary vaccines
    • a) Japan
    • b) United States of America
    • c) European Union
    • 3.14. Future Trends
    • a) Emerging diseases
    • b) New vaccine technologies

CHAPTER FOUR: VETERINARY PERFORMANCE ENHANCERS PRODUCTS MARKET

  • 4.1. Background
  • 4.2. Feed Additives
    • 4.2.1. Feed Composition
    • 4.2.2. Nutritional Feed Additives
      • a) Amino acids
      • b) Vitamins
      • c) Organic acids
    • 4.2.3. Medicated Feed Additives
      • a) Enzymes
      • b) Prebiotics, Probiotics
      • c) Hormones
    • 4.2.4. Feed Additives: Advantages
      • a) Improve animal diet.
      • b) Provide therapeutic benefit and reduce cost.
      • c) Increase feed conversion efficiency thereby leading to improved profitability.
  • 4.3. Market size and growth
    • 4.3.1. Market Growth Drivers
  • 4.4. Market Segments
    • 4.4.1. Nutritional Feed Additives Market
      • a) Amino acids
      • b) Vitamins
      • c) Organic Acids
    • 4.4.2. Medicated Feed Additives Market
      • a) Antibiotics
      • b) Probiotics and Prebiotics
      • c) Enzymes
      • d) Anti-protozoal agents
    • 4.4.2.1. Medicated Feed Additives: By Species (Poultry, Pigs, Cattle, Others), 2008
  • 4.5. Geographical Split
  • 4.6. Competition
  • 4.7. Implants and Injections
    • 4.7.1. Market Size and Growth
  • 4.8. Regulatory Framework
    • a) US
    • b) Europe
  • 4.9. Safety Issues

CHAPTER FIVE: VETERINARY OTC PRODUCTS MARKET

  • 5.1. Background
  • 5.2. Pet population trends
    • a) Greying human populace
    • b) Increasing life expectancy of pets
    • c) Advantages
  • 5.3. Market Size and Growth
  • 5.4. Market Segments
  • 5.5. Market Drivers
    • a) Rising pet ownership
    • b) Consumer behavior
    • c) Rx-to-OTC switch
    • d) Product quality
    • e) Price sensitivity
    • f) Improving distribution network
    • g) Increasing focus on Wellness
  • 5.6. Product Life-cycle Management
    • a) Broad customer group
    • b) New formulations
    • c) Creative marketing strategies
    • d) Distribution Structure
  • 5.7. Regulatory Issues

CHAPTER SIX: CORPORATE PROFILES

  • 6.1. Alpharma Animal Health
    • Background
    • Products
    • Revenues
    • Business Strategy
  • 6.2. Adisseo France S.A.S.
    • Background
    • Products
    • Business Strategy
    • Revenues
  • 6.3. BASF International
    • Background
    • Products
    • Revenues
  • 6.4. Bayer Healthcare
    • Background
    • Products
    • Revenues
  • 6.5. Boehringer Ingelheim GmbH
    • Background
    • Products
    • Revenues
  • 6.6. DSM Nutritional Products, Inc.
    • Background
    • Products
    • Revenues
  • 6.7. Elanco Animal Health
    • Background
    • Products
    • Revenues
  • 6.8. Fort Dodge Animal Health
    • Background
    • Products
    • Revenues
  • 6.9. Heska Corporation
    • Background
    • Products
    • Revenue
  • 6.10. Intervet Schering Plough Animal Health
    • Background
    • Products
    • Products
    • Revenues
  • 6.11. Merial Animal Health Ltd.
    • Background
    • Products
    • Revenues
  • 6.12. Novartis Animal Health Inc.
    • Background
    • Products
    • Farm animal products
    • Livestock animal products
  • 6.13. Virbac SA
    • Background
    • Revenues
    • Products
  • 6.14. Pfizer Animal Health
    • Background
    • Products
    • Revenues

CHAPTER ONE: VETERINARY HEALTH PRODUCTS MARKET STRATEGIC PERSPECTIVES

  • Exhibit 1: Worldwide Livestock Population, 2008
  • Exhibit 2: Worldwide Pet population, 2008
  • Exhibit 3: Market Share: Companion Animal vs. Food Production Animal
  • Exhibit 4: Worldwide Companion Animal Prescriptions and Vaccines Market, 2008
  • Exhibit 5: US Household Penetration of Pets (%), 2008
  • Exhibit 6: Worldwide Veterinary Health Products Market
  • Exhibit 7: Worldwide Veterinary Health Products Market: Market Segments ($ billion) and Growth (%) (2006-14)
  • Exhibit 8: Worldwide Veterinary Health Products Market:
  • Exhibit 9: Worldwide Veterinary Pharmaceuticals Market:
  • Exhibit 10: Worldwide Veterinary Pharmaceutical Products Market, 2006-14
  • Exhibit 11: Worldwide Veterinary Vaccines Market:
  • Exhibit 12: Veterinary Vaccines Market, 2006-14
  • Exhibit 13: Worldwide Veterinary Performance Enhancer Products Market:
  • Exhibit 14: Veterinary Performance Enhancers Market, 2006-14
  • Exhibit 15: Regional Share Break-up (%), 2008
  • Exhibit 16: Worldwide Veterinary Health Products Market:
  • Exhibit 17: Worldwide Veterinary Health Products Market by Region:
  • Exhibit 18: Veterinary Health Products Market by Species, 2008 (Ruminants, Pigs, Poultry, Companions, Others)
  • Exhibit 19: Veterinary Health Products Market: Leading Companies, 2008
  • Exhibit 20: Veterinary Health Products Industry: Mergers and Acquisitions Trends

CHAPTER TWO: VETERINARY PHARMACEUTICAL PRODUCTS MARKET

  • Exhibit 21: Veterinary Pharmaceutical Products Market, 2006-14 (US, Europe, ROW)
  • Exhibit 22: Veterinary Pharmaceutical Products Market, 2006-14 (US, Europe, ROW)
  • Exhibit 23: Veterinary Pharmaceutical Products Market, 2006-14 (Parasiticides, Anti-infectives, NSAIDS, Cardiovasculars, Hormones, CNS, Others)
  • Exhibit 24: Veterinary Pharmaceutical Products Market: Segment Share %, 2008
  • Exhibit 25: Generic vs. Branded Products 2008
  • Exhibit 26: Veterinary Anti-infective Products Market by Region (US, Europe, ROW), 2006-14
  • Exhibit 27: Veterinary Anti-inflammatory Products Market by Region (US, Europe, ROW), 2006-14
  • Exhibit 28: Veterinary Cardiovascular Products Market by Region (US, Europe, ROW), 2006-14
  • Exhibit 29: Veterinary Parasiticidal Products Market Veterinary Implants Market by Region (US, Europe, ROW), 2008-14
  • Exhibit 30: Veterinary CNS Disorders Products Market by Region (US, Europe, ROW), 2006-14
  • Exhibit 31: Veterinary Hormone Products Market by Region (US, Europe, ROW), 2006-14
  • Exhibit 32: Veterinary Pharmaceutical Products Market Share

CHAPTER THREE: VETERINARY VACCINES MARKET

  • Exhibit 33: Trade of Livestock in Millions of Tons (Beef, Pork, Poultry) 2001-2014
  • Exhibit 36: Disease Outbreak: Direct versus Indirect cost comparison
  • Exhibit 34: Veterinary Vaccines Market by Region (US, Europe, ROW), 2006-14
  • Exhibit 35: Veterinary Vaccines Market by Region (US, Europe, ROW), 2006-14
  • Exhibit 36: Veterinary Vaccines Market by Region (USA, Europe, ROW)
  • Exhibit 37: Veterinary Vaccine Sales by Species (Livestock, Poultry, Other)
  • Exhibit 38: Veterinary Vaccines, Competitive Share, 2008

CHAPTER FOUR: VETERINARY PERFORMANCE ENHANCERS PRODUCTS MARKET

  • Exhibit 40: Veterinary Performance Enhancers Market, 2006-14
  • Exhibit 41: Veterinary Performance Enhancers: Segment Share(Medicated Feed Additives, Nutritional Feed Additives, Implants and Injections), 2008
  • Exhibit 42: Worldwide Nutritional Feed Additives Market(Amino Acids, Vitamins, Organic Acids), 2006-14
  • Exhibit 43: Veterinary Nutritional Feed Additives: Segment Share, 2008
  • Exhibit 44: Worldwide Medicated Feed Additives Market (Antibiotics, Enzymes, Probiotics and Prebiotics, Anti-protozoals), 2006-14
  • Exhibit 45; Worldwide Medicated Feed Additives: Segment Share, 2008
  • Exhibit 46: Veterinary Performance Enhancers Market, Competitive Share, 2008
  • Exhibit 47: Veterinary Feed Additives Market by Geography (US, Europe, ROW), 2008
  • Exhibit 48: Veterinary Performance Enhancers Market, Competitive Share, 2008
  • Exhibit 49: Veterinary Implants Market by Region (US, Europe, ROW), 2006-14
  • Exhibit 50: Veterinary Implants Market by Region (US, Europe, ROW), 2006-14

CHAPTER FIVE: VETERINARY OTC PRODUCTS MARKET

  • Exhibit 51: Pet Population (Dogs, Cats Rabbits, Horses) by Region (US, Europe, Global) 2008
  • Exhibit 52: Veterinary OTC Health Products Market, 2006-14
  • Exhibit 53: Veterinary OTC Health Products Market
  • Exhibit 54: Veterinary OTC Health Products Market by Segments (Parasiticides, NSAIDS, Vitamins, GI Disorders, Cold and Cough, Others) 2006-14
  • Exhibit 55: US Household Pet Ownership (Dogs, Cats, Birds, Horses)
Back to Top